Home › Employers › Ansa Biotechnologies Inc.
Ansa Biotechnologies Inc.: H-1B salaries and sponsorship
Ansa Biotechnologies Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $140,000.
Does Ansa Biotechnologies Inc. sponsor H-1B visas?
Ansa Biotechnologies Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Sep 26, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Production Scientist | 1 | $140,000 |
| Strategic Account Executive | 1 | $185,000 |
| Associate Automation Engineer | 1 | $106,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $140,000 |
| FY2024 | 1 | $185,000 |
| FY2026 | 1 | $106,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Associate Automation Engineer | $106,000–$120,000 Level II | Emeryville, CA | Sep 26, 2025 | Oct 6, 2025 | Certified |
| Strategic Account Executive | $185,000–$232,000 Level II | Nashville, TN | Jul 15, 2024 | Aug 6, 2024 | Certified |
| Production Scientist | $140,000–$160,000 Level III | Emeryville, CA | Jun 8, 2023 | Aug 1, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).